Last Updated: September 24, 2026

Litigation Details for Polaris PowerLED Technologies, LLC v. Dell Technologies Inc. (W.D. Tex. 2022)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in Polaris PowerLED Technologies, LLC v. Dell Technologies Inc.
The small molecule drug covered by the patent cited in this case is ⤷  Start Trial .

Litigation Summary: Polaris PowerLED Technologies, LLC v. Dell Technologies Inc. (D. Del. 1:22-cv-00973) Patent Claims, Procedural Posture, and Exposure Analysis

Last updated: July 1, 2026

Polaris PowerLED Technologies, LLC v. Dell Technologies Inc., No. 1:22-cv-00973 (D. Del.) is a patent infringement case filed in 2022 by Polaris PowerLED Technologies against Dell Technologies. The matter is a “standard” US patent litigation profile in the sense that it centers on alleged infringement of one or more asserted US patents covering PowerLED-related LED/lighting technology, but the provided record does not include the specific asserted patents, asserted claims, claim construction rulings, infringement contentions, or any final disposition. Without the complaint’s asserted patent list and the docket’s key merits events, a complete, accurate litigation summary and analysis cannot be produced under the constraints.

What patents are asserted in Polaris PowerLED Technologies v. Dell (1:22-cv-00973)?

Answer: Not determinable from the information provided.

Which patent numbers and assignees are listed in the complaint?

Answer: Not determinable from the information provided.

What technologies do the asserted patents cover (LED architecture, driver control, optics, thermal, or packaging)?

Answer: Not determinable from the information provided.

What does Polaris allege that Dell infringes in the PowerLED patents?

Answer: Not determinable from the information provided.

Which Dell product lines are accused (monitors, displays, lighting modules, servers)?

Answer: Not determinable from the information provided.

What infringement theories are pleaded (direct infringement, induced infringement, contributory infringement)?

Answer: Not determinable from the information provided.

Does Polaris claim Dell sells, offers for sale, or uses in the US?

Answer: Not determinable from the information provided.

What procedural posture does the case have in 1:22-cv-00973?

Answer: Not determinable from the information provided.

Complaint filing date and venue specifics

Answer: Not determinable from the information provided.

Any amended pleadings and when

Answer: Not determinable from the information provided.

Scheduling and key milestones (Markman, claim construction, expert reports, summary judgment)

Answer: Not determinable from the information provided.

What is the Markman and claim construction history in Polaris PowerLED v. Dell?

Answer: Not determinable from the information provided.

What claim terms did the court construe?

Answer: Not determinable from the information provided.

Did the court narrow claims materially that affect infringement?

Answer: Not determinable from the information provided.

What defenses has Dell asserted in Polaris PowerLED Technologies v. Dell?

Answer: Not determinable from the information provided.

Invalidity defenses (anticipation, obviousness, indefiniteness)

Answer: Not determinable from the information provided.

Non-infringement defenses (non-practicing features, design-arounds)

Answer: Not determinable from the information provided.

Procedural defenses (venue, standing, jurisdiction, inequitable conduct)

Answer: Not determinable from the information provided.

What does a district court docket show about motions practice?

Answer: Not determinable from the information provided.

Motions to dismiss, transfer, or stay

Answer: Not determinable from the information provided.

Daubert motions and evidentiary rulings

Answer: Not determinable from the information provided.

Summary judgment outcomes

Answer: Not determinable from the information provided.

Was there any PTAB activity linked to Polaris PowerLED’s patents?

Answer: Not determinable from the information provided.

IPRs or PGRs that challenge the asserted patents

Answer: Not determinable from the information provided.

Estoppel implications for later district-court invalidity positions

Answer: Not determinable from the information provided.

What settlement or disposition occurred in 1:22-cv-00973?

Answer: Not determinable from the information provided.

Is the case ongoing, dismissed, stayed, or resolved by settlement?

Answer: Not determinable from the information provided.

Any consent judgment, covenant not to sue, or license agreement

Answer: Not determinable from the information provided.

How much damages exposure could Dell face in Polaris PowerLED v. Dell?

Answer: Not determinable from the information provided.

Damages theories (reasonable royalty, lost profits, running royalty)

Answer: Not determinable from the information provided.

Notice dates and pre-suit damages cutoffs

Answer: Not determinable from the information provided.

Willfulness and enhanced damages posture

Answer: Not determinable from the information provided.

What commercial and licensing implications follow from this litigation?

Answer: Not determinable from the information provided.

How the asserted technology likely affects Dell product roadmap and sourcing

Answer: Not determinable from the information provided.

Typical licensing range indicators from similar LED patent disputes

Answer: Not determinable from the information provided.

Key Takeaways

  • The case identifier is clear: Polaris PowerLED Technologies, LLC v. Dell Technologies Inc., 1:22-cv-00973 (D. Del.).
  • A litigation summary requires docket and pleading facts (asserted patents/claims, infringement contentions, claim construction rulings, motions, and outcomes). Those facts are not present in the information provided.
  • No defensible analysis of validity, infringement, exposure, or settlement posture can be stated without the asserted patent list and the case’s procedural milestones.

FAQs

  1. What asserted patents does Polaris PowerLED Technologies list against Dell in 1:22-cv-00973?
    Not determinable from the information provided.

  2. What claim construction did the court issue in Polaris PowerLED Technologies v. Dell?
    Not determinable from the information provided.

  3. Has Dell moved to stay the case pending PTAB review of the asserted patents?
    Not determinable from the information provided.

  4. Did the parties reach a settlement or dismissal in 1:22-cv-00973?
    Not determinable from the information provided.

  5. What are the likely damages theories (reasonable royalty vs lost profits) and notice dates?
    Not determinable from the information provided.

References

  1. Court case caption and docket identifier provided by the prompt: Polaris PowerLED Technologies, LLC v. Dell Technologies Inc., No. 1:22-cv-00973 (D. Del.).

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.